The manufacturing strategy of an API needs to be carefully configured to support all points in its life cycle. Whether an API is in an introduction, growth or maturity phase will decisively determine its manufacturing process requirements. In this webinar, we will use case studies to examine how Cambrex manages the API life cycle through innovation, process and cost improvement. By carefully considering our customer’s API life cycle prerequisites, Cambrex can provide large, mid-size and emerging pharmaceutical companies additional opportunities to meet their changing small molecule needs. Ultimately, this helps bring customers’ products to market quickly while supporting the API life cycle through to maturity.
Cambrex’s innovative product group will detail their objective and describe how customers can benefit from their innovative approach to develop new sustainable routes or processes, by which additional IP protection can be generated, cost of goods lessened, and/or environmental footprints reduced.
Join us as we explore and showcase how Cambrex can manage your API life cycle through innovation, process and cost improvements, to meet your API development needs and help you move your products quickly to market.
Jonathan Knight, VP of New Product Development, Cambrex
Since joining Cambrex in 1996, Jonathan has had a number of commercial roles, including V.P Sales & Marketing for the Cambrex Innovative Pharmaceutical Business Unit. In the beginning of 2012, Jonathan established the Innovative Product Group within Cambrex, which comprises a dedicated team responsible for developing new innovative proprietary products.Message Presenter
Margus Eek, Head of R&D, Cambrex Tallinn
Margus Eek is the head of R&D of Cambrex Tallinn. He has been with Cambrex Tallinn (formally Prosyntest) since the group was acquired in 2008 and manages a world class group of R&D chemists. Margus has an MSc in 1984 from the University of Tartu.Message Presenter
Lars Eklund, Technical Lead, Cambrex
Since joining Cambrex in 1994, Lars has held a number of technical roles within the R&D Department. Since 2012, he has been the Technical Lead within the Innovative Product Group, for Cambrex. He has a Ph.D. in Organic Chemistry from the University of Umeå, Sweden.Message Presenter
Who Should Attend?
Sourcing, procurement, project managers, supplier managers, contract manufacturing managers, R&D Chemists, process chemists, CEOs.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic Pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.